Searchable abstracts of presentations at key conferences in endocrinology

ea0081p163 | Pituitary and Neuroendocrinology | ECE2022

Clinical applicability of using SAGIT instrument and AcroQol in the management of patients with acromegaly

Herman Rok , Goricar Katja , Janez Andrej , Jensterle Mojca

Objective: We aimed to evaluate the ability of SAGIT Instrument and AcroQoL questionnaire to discriminate acromegaly control status and to correlate SAGIT scores to AcroQoL results in a cohort of the national referral centre.Methods: Cross-sectional study included 72 patients followed between 2000 and 2020. We retrospectively determined SAGIT score at the diagnosis. Based on the data from the most recent follow up and additional telephone interviews, we ...

ea0070aep504 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Genetic variability in antioxodative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome

Herman Rok , Jensterle Mojca , Janez Andrej , Goricar Katja , Dolzan Vita

Background: Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder of multifactorial etiopathology likely to involve the interactions between genetics and lifestyle. Chronic inflammation and oxidative stress (OS) may participate in the pathophysiology of the syndrome. The question of the extent to which OS and inflammation are causally related to the development of the syndrome and metabolic complications remains unanswered. Furthermore, the role of NLR...

ea0099rc1.2 | Rapid Communications 1: Reproductive and Developmental Endocrinology | ECE2024

Endometrial transcriptome alterations following short-term liraglutide treatment in infertile women with polycystic ovary syndrome and obesity

Jensterle Mojca , Salamun Vesna , Vrtacnik Bokal Eda , Lovrecic Luca , Maver Ales , Peterlin Borut , Herman Rok , Janez Andrej

Objective: Obesity and polycystic ovary syndrome (PCOS) affect endomertial receptivity and may cause implantation failure, defective placentation, and pregnancy loss. Glucagon-like peptide-1 (GLP-1) receptor agonist (RA) improved the endometrial function in animal models, presumably by anti-inflammatory action and reduction of endometrial fibrosis. The impact of GLP-1RA on human endometrioum has not yet been investigated.Aim: We compared endometrial tran...